American Journal of Ophthalmology
Volume 137, Issue 2 , Pages 219-227, February 2004

The confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study: study design and baseline factors☆

  • Linda M Zangwill

      Affiliations

    • Departments ofdepartment of Ophthalmology (L.M.Z., R.N.W., A.R.S., K.A.D.), University of California at San Diego, La Jolla, California, USA
    • Corresponding Author InformationInquiries to Linda M. Zangwill, PhD, Diagnostic Imaging Laboratory, Hamilton Glaucoma Center and Department of Ophthalmology, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA 92093-0946, USA; fax: (858) 534-1625
    • ,
  • Robert N Weinreb

      Affiliations

    • Departments ofdepartment of Ophthalmology (L.M.Z., R.N.W., A.R.S., K.A.D.), University of California at San Diego, La Jolla, California, USA
    • ,
  • Charles C Berry

      Affiliations

    • department of Family and Preventive Medicine (C.C.B.), University of California at San Diego, La Jolla, California, USA
    • ,
  • Amanda R Smith

      Affiliations

    • Departments ofdepartment of Ophthalmology (L.M.Z., R.N.W., A.R.S., K.A.D.), University of California at San Diego, La Jolla, California, USA
    • ,
  • Keri A Dirkes

      Affiliations

    • Departments ofdepartment of Ophthalmology (L.M.Z., R.N.W., A.R.S., K.A.D.), University of California at San Diego, La Jolla, California, USA
    • ,
  • Jeffrey M Liebmann

      Affiliations

    • New York Eye and Ear Infirmary (J.M.L.), New York, New York, USA
    • ,
  • James D Brandt

      Affiliations

    • University of California at Davis (J.D.B.), Sacramento, California, USA
    • ,
  • Gary Trick

      Affiliations

    • Henry Ford Medical Center (G.T.), Troy, Michigan, USA
    • ,
  • George A Cioffi

      Affiliations

    • Devers Eye Institute (G.A.C.), Portland, Oregon, USA
    • ,
  • Anne L Coleman

      Affiliations

    • Jules Stein Eye Institute (A.L.C.), University of California at Los Angeles, Los Angeles, California, USA
    • ,
  • Jody R Piltz-Seymour

      Affiliations

    • Scheie Eye Institute (J.R.P.-S.), University of Pennsylvania, Philadelphia, Pennsylvania, USA
    • ,
  • Mae O Gordon

      Affiliations

    • Department of Ophthalmology and Visual Sciences (M.O.G., M.A.K.), Washington University School of Medicine, St. Louis, Missouri, USA
    • ,
  • Michael A Kass

      Affiliations

    • Department of Ophthalmology and Visual Sciences (M.O.G., M.A.K.), Washington University School of Medicine, St. Louis, Missouri, USA
    • ,
  • THE OHTS CSLO ANCILLARY STUDY GROUP

Accepted 10 August 2003.

Abstract 

Purpose

To describe the study design of the Confocal Scanning Laser Ophthalmoscopy (CSLO) Ancillary Study to the Ocular Hypertension Treatment Study (OHTS) and to examine the associations between optic disk topography, and baseline demographic, clinical, and ocular factors at study entry.

Design

A randomized clinical trial.

Methods

Participants in this ancillary study were recruited from seven of the 22 OHTS clinical centers. Each participant completed imaging annually using a CSLO, the Heidelberg Retina Tomograph (HRT). Associations between HRT topographic optic disk measurements and intraocular pressure (IOP), baseline photographic estimates of horizontal and vertical cup-to-disk diameter ratios by the OHTS Optic Disk Reading Center, baseline visual field indices, and demographic and clinical factors were assessed using linear mixed effects models.

Results

Four hundred thirty-nine participants had good quality images and were included in this baseline analysis. No associations between HRT topographic optic disk measurements and diabetes, systemic hypertension, cardiovascular disease, IOP, or visual function were found. The HRT topographic optic disk measurements were associated with baseline stereophotographic estimates of horizontal and vertical cup-to-disk diameter ratios. The strongest associations were found between stereophotographic assessment of horizontal and vertical cup-to-disk diameter ratios, and HRT cup-to-disk area ratio (r = .85 and .84, respectively), rim-to-disk area ratio (r = −.85 and −.84, respectively), mean cup depth (r = .84 and .83, respectively), and cup area (r = .83 and .80, respectively). After adjusting for optic disk area, all HRT topographic optic disk measurements remained associated with stereophotographic assessment of horizontal and vertical cup-to-disk diameter ratios.

Conclusions

The CSLO ancillary study to the OHTS is the first multicenter clinical trial to use CSLO imaging to monitor changes in the optic disk. At study entry, HRT topographic measurements corresponded well with both horizontal and vertical stereophotographic-based estimates of cup-to-disk diameter ratio in ocular hypertensive participants.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

☆ This study was supported by Grants EY11158, EY09341, and EY09307 from the National Eye Institute and the National Center of Minority Health and Health Disparities, National Institutes of Health, Bethesda, Maryland; Merck Research Laboratories, White House Station; and by an unrestricted grant from Research to Prevent Blindness, New York, New York. The authors have received support from the following companies: R.N.Weinreb: consultant or honoraria from Alcon and Novartis; consultant or honoraria and grant support or patent received/pending from Allergan Therapeutics, Heidelberg Engineering, Humphrey Instruments, Merck Research Laboratories, and Pharmacia/Upjohn; owns stock in Merck. J. M. Liebmann: consultant or honoraria from Allergan Therapeutics, Heidelberg Engineering, Novartis, and Pharmacia/Upjohn. J. D. Brandt: consultant or honoraria from Allergan, Merck, and Pharmacia/Upjohn. G. A. Cioffi: consultant or honoraria from Merck, Alcon Laboratories; consultant or honoraria and grant support/patent from Allergan, Ciba Vision, Heidelberg Engineering, Humphrey Instruments, Novartis, and Pharmacia/Upjohn. A. L. Coleman: grant support from Alcon Laboratories, consultant or honoraria from Allergan Therapeutics and Pharmacia/Upjohn. J. R. Piltz-Seymour: consultant or honoraria from Alcon, Allergan, Merck, and Pharmacia/Upjohn. M. A. Kass: consultant or honoraria from Merck and Pharmacia/Upjohn. L. M. Zangwill: research support (equipment) from Heidelberg Engineering, Laser Diagnostic Technologies, and Carl Zeiss Meditec.

PII: S0002-9394(03)00969-3

doi:10.1016/j.ajo.2003.08.031

American Journal of Ophthalmology
Volume 137, Issue 2 , Pages 219-227, February 2004

Article Tools